Skip to content

Author

Yong Li

We have 1 of 22 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Lipid Nanoparticles Based Multi-Scale Systemic Immune Programming for Cancer Therapy.

A dual-track therapeutic paradigm that integrates tumor-directed immune activation with host physiological restoration is proposed, which positions LNP-based therapies to treat cancer as a systemic immune-metabolic disorder rather than a localized disease.

Xinwen Lin, Yong Li, Xi-Ling Shen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.